-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2017 to Q1 2023.
- RVL Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was -$4.86M, a 481% decline year-over-year.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $41.8M.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$135M, a 3775% decline from 2020.
- RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $3.68M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)